{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:14:52Z","timestamp":1792199692601,"version":"4.4.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00869","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T04:25:32Z","timestamp":1533529532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT3 Antagonist, Palonosetron and With the NK1 Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)"],"prefix":"10.3389","volume":"9","author":[{"given":"John A.","family":"Rudd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man P.","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longlong","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengbing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Lovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pietra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1530\/eje.0.1500447","article-title":"Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects.","volume":"150","author":"Akamizu","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046321","article-title":"The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence.","volume":"7","author":"Alvarez-Crespo","year":"2012","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-3-642-18891-6_12","article-title":"\u201cThe role of tachykinins and the tachykinin receptor in nausea and emesis,\u201d in","author":"Andrews","year":"2004","journal-title":"Handbook of Experimental Pharmacology"},{"key":"B4","article-title":"\u201cThe physiology and pharmacology of nausea and vomiting induced by anti-cancer chemotherapy in humans,\u201d in","author":"Andrews","year":"2015","journal-title":"Management of Chemotherapy-Induced Nausea and Vomiting: New Agents and New Uses of Current Agents"},{"key":"B5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.physbeh.2005.01.010","article-title":"Potential energetic implications of emesis in the house musk shrew (Suncus murinus).","volume":"84","author":"Andrews","year":"2005","journal-title":"Physiol. Behav."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086730","article-title":"Identification of neural networks that contribute to motion sickness through principal components analysis of fos labeling induced by galvanic vestibular stimulation.","volume":"9","author":"Balaban","year":"2014","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0031-9384(87)90250-2","article-title":"Further studies on nicotine-induced emesis: nicotinic mediation in area postrema.","volume":"39","author":"Beleslin","year":"1987","journal-title":"Physiol. Behav."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2016.00014","article-title":"Moving in a moving world: a review on vestibular motion sickness.","volume":"7","author":"Bertolini","year":"2016","journal-title":"Front Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.3747\/co.19.1074","article-title":"Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting.","volume":"19","author":"Bouganim","year":"2012","journal-title":"Curr. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1016\/0014-2999(93)90673-6","article-title":"Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets.","volume":"249","author":"Bountra","year":"1993","journal-title":"Eur. J. Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/cne.23309","article-title":"Expression of the ghrelin receptor gene in neurons of the medulla oblongata of the rat.","volume":"521","author":"Bron","year":"2013","journal-title":"J. Comp. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/nmo.12490","article-title":"Emerging treatments in neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist.","volume":"27","author":"Camilleri","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"B13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuropharm.2014.03.016","article-title":"The differential antiemetic properties of GLP-1 receptor antagonist, exendin (9-39) in Suncus murinus (house musk shrew).","volume":"83","author":"Chan","year":"2014","journal-title":"Neuropharmacology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0028-3908(90)90167-P","article-title":"Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret.","volume":"29","author":"Costall","year":"1990","journal-title":"Neuropharmacology"},{"key":"B15","first-page":"29","article-title":"\u201cNeurophysiology of motion sickness,\u201d in","author":"Crampton","year":"1990","journal-title":"Motion and Space Sickness"},{"key":"B16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2217\/fon.14.14","article-title":"Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome.","volume":"10","author":"Currow","year":"2014","journal-title":"Future Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pbb.2015.02.010","article-title":"Differential and additive suppressive effects of 5-HT3 (palonosetron)- and NK1 (netupitant)-receptor antagonists on cisplatin-induced vomiting and ERK1\/2, PKA and PKC activation.","volume":"131","author":"Darmani","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B18","doi-asserted-by":"publisher","first-page":"R902","DOI":"10.1152\/ajpregu.90952.2008","article-title":"Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus).","volume":"296","author":"De Jonghe","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1476-5381.1995.tb13283.x","article-title":"Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo.","volume":"114","author":"Eglen","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1113\/jphysiol.2014.284240","article-title":"Visually induced nausea causes characteristic changes in cerebral, autonomic and endocrine function in humans.","volume":"593","author":"Farmer","year":"2015","journal-title":"J. Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0167-0115(96)00071-7","article-title":"GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity.","volume":"65","author":"Gardner","year":"1996","journal-title":"Regul Pept."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1111\/j.1476-5381.1995.tb15118.x","article-title":"The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.","volume":"116","author":"Gardner","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/WCO.0000000000000163","article-title":"Pathophysiology and treatment of motion sickness.","volume":"28","author":"Golding","year":"2015","journal-title":"Curr. Opin. Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/annonc\/mdu096","article-title":"A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy.","volume":"25","author":"Gralla","year":"2014","journal-title":"Ann. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1517\/14656566.4.12.2297","article-title":"Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis.","volume":"4","author":"Grunberg","year":"2003","journal-title":"Expert Opin. Pharmacother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMra0706547","article-title":"Chemotherapy-induced nausea and vomiting.","volume":"358","author":"Hesketh","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/annonc\/mdu110","article-title":"Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.","volume":"25","author":"Hesketh","year":"2014","journal-title":"Ann. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1002\/cncr.27430","article-title":"Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study.","volume":"118","author":"Hiura","year":"2012","journal-title":"Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"G25","DOI":"10.1152\/ajpgi.00366.2009","article-title":"Food restriction, refeeding, and gastric fill fail to affect emesis in musk shrews.","volume":"298","author":"Horn","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.peptides.2009.01.006","article-title":"Identification of ghrelin in the house musk shrew (Suncus murinus): cDNA cloning, peptide purification and tissue distribution.","volume":"30","author":"Ishida","year":"2009","journal-title":"Peptides"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1566-0702(03)00026-2","article-title":"Induction of Fos protein in neurons in the medulla oblongata after motion- and X-irradiation-induced emesis in musk shrews (Suncus murinus).","volume":"107","author":"Ito","year":"2003","journal-title":"Auton. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1538\/expanim.54.301","article-title":"Emetic responses and neural activity in young musk shrews during the breast-feeding\/weaning period: comparison between the high and low emetic response strains using a shaking stimulus.","volume":"54","author":"Ito","year":"2005","journal-title":"Exp. Anim."},{"key":"B33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejphar.2006.06.034","article-title":"Differential action of anti-emetic drugs on defecation and emesis induced by prostaglandin E2 in the ferret.","volume":"544","author":"Kan","year":"2006","journal-title":"Eur. J. Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1111\/nmo.12459","article-title":"New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson\u2019s disease.","volume":"26","author":"Karasawa","year":"2014","journal-title":"Neurogastroenterol. Motil."},{"key":"B35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/nmo.12459","article-title":"A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew).","volume":"174","author":"Kwiatkowska","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"B36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0022-3565(25)11981-2","article-title":"Emetic action of nicotine and lobeline.","volume":"121","author":"Laffan","year":"1957","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/00008877-200512000-00002","article-title":"Action of ondansetron and CP-99,994 on cisplatin-induced emesis and locomotor activity in Suncus murinus (house musk shrew).","volume":"16","author":"Lau","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1177\/147323000703500409","article-title":"Predictive models for post-operative nausea and vomiting in patients using patient-controlled analgesia.","volume":"35","author":"Lee","year":"2007","journal-title":"J. Int. Med. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2217\/fon.14.260","article-title":"Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting.","volume":"11","author":"Lorusso","year":"2015","journal-title":"Future Oncol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/415450","article-title":"Changes in plasma ghrelin and serum leptin levels after Cisplatin-based transcatheter arterial infusion chemotherapy for hepatocellular carcinoma.","volume":"2013","author":"Matsumura","year":"2013","journal-title":"ISRN Gastroenterol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064777","article-title":"The role of the vagus nerve in the migrating motor complex and ghrelin- and motilin-induced gastric contraction in suncus.","volume":"8","author":"Miyano","year":"2013","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060365","article-title":"Mechanism of ghrelin-induced gastric contractions in Suncus murinus (house musk shrew): involvement of intrinsic primary afferent neurons.","volume":"8","author":"Mondal","year":"2013","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin.","volume":"4","author":"Muller","year":"2015","journal-title":"Mol Metab"},{"key":"B44","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3109\/14767058.2011.598588","article-title":"Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum.","volume":"25","author":"Mullin","year":"2012","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/DDDT.S76158","article-title":"Profile of netupitant\/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV).","volume":"9","author":"Navari","year":"2015","journal-title":"Drug design, development and therapy"},{"key":"B46","doi-asserted-by":"publisher","first-page":"R233","DOI":"10.1152\/ajpregu.00078.2011","article-title":"Interdigestive migrating contractions are coregulated by ghrelin and motilin in conscious dogs.","volume":"302","author":"Ogawa","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0196-9781(03)00159-1","article-title":"Hypothalamic paraventricular injections of ghrelin: effect on feeding and c-Fos immunoreactivity.","volume":"24","author":"Olszewski","year":"2003","journal-title":"Peptides"},{"key":"B48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3233\/VES-2011-0432","article-title":"Are evolutionary hypotheses for motion sickness \u201cjust-so\u201d stories? J Vestib Res","author":"Oman","year":"2012"},{"key":"B49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejphar.2013.09.070","article-title":"Conditioned flavor avoidance and conditioned gaping: rat models of conditioned nausea.","volume":"722","author":"Parker","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1113\/expphysiol.2009.052001","article-title":"Telemetry in a motion-sickness model implicates the abdominal vagus in motion-induced gastric dysrhythmia.","volume":"95","author":"Percie du Sert","year":"2010","journal-title":"Exp. Physiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.peptides.2015.03.021","article-title":"In vitro and in vivo pharmacological characterization of the novel NK1 receptor selective antagonist Netupitant.","volume":"37","author":"Rizzi","year":"2012","journal-title":"Peptides"},{"key":"B52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00520-016-3365-1","article-title":"2016 updated MASCC\/ESMO consensus recommendations: prevention of nausea and vomiting following moderately emetogenic chemotherapy.","volume":"25","author":"Roila","year":"2017","journal-title":"Support Care Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1124\/jpet.110.166181","article-title":"The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo.","volume":"335","author":"Rojas","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B54","first-page":"15","article-title":"\u201cMechanisms of acute, delayed and anticipatory vomiting in cancer and cancer treatment,\u201d in","author":"Rudd","year":"2004","journal-title":"Management of Nausea and Vomiting in Cancer and Cancer Treatment"},{"key":"B55","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1476-5381.1996.tb15761.x","article-title":"The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret.","volume":"119","author":"Rudd","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0014-2999(98)00920-0","article-title":"Inhibition of emesis by tachykinin NK1 receptor antagonists in Suncus murinus (house musk shrew).","volume":"366","author":"Rudd","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00263","article-title":"Profile of antiemetic activity of netupitant alone or in combination with palonosetron and dexamethasone in ferrets and Suncus murinus (house musk shrew).","volume":"7","author":"Rudd","year":"2016","journal-title":"Front Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2005.08.062","article-title":"Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.","volume":"392","author":"Rudd","year":"2006","journal-title":"Neurosci. Lett."},{"key":"B59","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1620\/tjem.219.177","article-title":"Cisplatin ototoxicity and protection: clinical and experimental studies.","volume":"219","author":"Rybak","year":"2009","journal-title":"Tohoku J. Exp. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0014-2999(03)01863-6","article-title":"Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew).","volume":"472","author":"Sam","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejphar.2013.06.031","article-title":"The relationship between gastric motility and nausea: gastric prokinetic agents as treatments.","volume":"715","author":"Sanger","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1074\/jbc.M112.382473","article-title":"Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling.","volume":"288","author":"Schellekens","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/DCR.0b013e31829196d0","article-title":"Safety and efficacy of ulimorelin administered postoperatively to accelerate recovery of gastrointestinal motility following partial bowel resection: results of two randomized, placebo-controlled phase 3 trials.","volume":"56","author":"Shaw","year":"2013","journal-title":"Dis. Colon. Rectum."},{"key":"B64","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1345\/aph.1L437","article-title":"Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.","volume":"43","author":"Shih","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.peptides.2012.04.019","article-title":"Molecular identification of GHS-R and GPR38 in Suncus murinus.","volume":"36","author":"Suzuki","year":"2012","journal-title":"Peptides"},{"key":"B66","first-page":"81","article-title":"The evaluation of whole-body plethysmography as a semiautomated method for analysis of emesis in the house musk shrew (Suncus murinus).","volume":"46","author":"Tashiro","year":"2007","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1210\/endo.143.4.8712","article-title":"Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats.","volume":"143","author":"Tolle","year":"2002","journal-title":"Endocrinology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1254\/jjp.55.107","article-title":"Selective blockade of cytotoxic drug-induced emesis by 5-HT3 receptor antagonists in Suncus murinus.","volume":"55","author":"Torii","year":"1991","journal-title":"Jpn. J. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00412","article-title":"Brain activation by H1 antihistamines challenges conventional view of their mechanism of action in motion sickness: a behavioral, c-fos and physiological study in Suncus murinus (House Musk Shrew).","volume":"8","author":"Tu","year":"2017","journal-title":"Front. Physiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jphs.2017.03.001","article-title":"Action of Bacopa monnieri to antagonize cisplatin-induced emesis in Suncus murinus (house musk shrew).","volume":"133","author":"Ullah","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"B71","first-page":"240","article-title":"Use of antiemetics in the prevention of chemotherapy-induced nausea and vomiting: review and focus on the Belgian situation.","volume":"77","author":"Van den Brande","year":"2014","journal-title":"Acta Gastroenterol. Belg."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18050986","article-title":"Oral Treatment with the ghrelin receptor agonist HM01 attenuates cachexia in mice bearing colon-26 (C26) tumors.","volume":"18","author":"Villars","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5085(19)36357-7","article-title":"A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulfate and cardiac glycosides.","volume":"22","author":"Wang","year":"1952","journal-title":"Gastroenterology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1476-5381.1995.tb16324.x","article-title":"The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.","volume":"115","author":"Watson","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1476-5381.1995.tb13282.x","article-title":"The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.","volume":"114","author":"Wong","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s00221-014-3937-6","article-title":"Integration of vestibular and emetic gastrointestinal signals that produce nausea and vomiting: potential contributions to motion sickness.","volume":"232","author":"Yates","year":"2014","journal-title":"Exp. Brain Res."}],"updated-by":[{"DOI":"10.3389\/fphar.2018.01102","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00869\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T06:24:17Z","timestamp":1751783057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00869\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":76,"alternative-id":["10.3389\/fphar.2018.00869"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00869","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fphar.2018.01102","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"article-number":"869"}}